PUBLISHER: Grand View Research | PRODUCT CODE: 2040686
PUBLISHER: Grand View Research | PRODUCT CODE: 2040686
The global clinical data analytics solutions market size was estimated at USD 5.4 billion in 2025 and is projected to reach USD 9.0 billion by 2033, growing at a CAGR of 6.5% from 2026 to 2033. This growth is driven by rapid advancements in artificial intelligence (AI) and machine learning, which enhance diagnostic accuracy by identifying patterns in large datasets such as electronic health records (EHRs) and medical imaging, enabling improved prediction of patient outcomes and disease risks.
The rising demand for personalized diagnostic tests and treatments has led to a significant increase in clinical trials, generating vast volumes of data that require advanced analytics solutions for effective interpretation. This trend is accelerating the adoption of clinical data analytics platforms. For instance, in August 2023, Lokavant introduced a study planning solution that enables contract research organizations and sponsors to optimize site selection and overall study performance. The growing focus on population health management further supports market expansion.
Moreover, several initiatives by market players are strengthening the adoption of advanced analytics tools. For instance, in September 2024, Komodo Health expanded its MapLab platform with the launch of MapAI and MapExplorer, enhancing collaborative analytics and enabling simplified, no-code access to patient, provider, and payer insights through AI-driven capabilities.
Global Clinical Data Analytics Solutions Market Report Segmentation
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global clinical data analytics solutions market report based on deployment, application, and region: